166 related articles for article (PubMed ID: 35717565)
1. LncRNA DS Cell Adhesion Molecule Antisense RNA 1 Facilitates Oral Squamous Cell Carcinoma Progression through The microRNA-138-5p/ Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Axis.
Zhang Y; Wang X; Wang P; Zhang X; Han SH; Huo F
Cell J; 2022 May; 24(5):222-229. PubMed ID: 35717565
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA DSCAM-AS1 Facilitates Proliferation and Migration of Hemangioma Endothelial Cells by Targeting miR-411-5p/TPD52 Axis.
Wang Y; Zhai S; Xing J; Zhang J; He Y; Wang G; Li T
Biomed Res Int; 2022; 2022():8696432. PubMed ID: 36267843
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA Down syndrome cell adhesion molecule-anti-sense 1 promotes gastric carcinoma cell proliferation and migration by regulating the miR-204/TPT1 axis.
Wang N; Yang Y; Jia GZ; Wang K; Zhou S; Zhang B; Zhang ZS; Qiao Q; He XL
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S187-S195. PubMed ID: 34372727
[No Abstract] [Full Text] [Related]
4. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis.
Huang X; Wang Z; Hou S; Yue C; Li Z; Hu W; Lu H
Bioengineered; 2022 Feb; 13(2):4153-4165. PubMed ID: 35142595
[TBL] [Abstract][Full Text] [Related]
6. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma.
Cao X; Luan K; Yang J; Huang Y
Dis Markers; 2021; 2021():3138046. PubMed ID: 34457087
[TBL] [Abstract][Full Text] [Related]
7. Up-Regulation of FSTL3, Regulated by lncRNA DSCAM-AS1/miR-122-5p Axis, Promotes Proliferation and Migration of Non-Small Cell Lung Cancer Cells.
Gao L; Chen X; Wang Y; Zhang J
Onco Targets Ther; 2020; 13():2725-2738. PubMed ID: 32280246
[TBL] [Abstract][Full Text] [Related]
8. lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma.
Xiao L; Wang W; Zhao J; Xu H; Li S; Yang X
Oncol Lett; 2020 Nov; 20(5):164. PubMed ID: 32934732
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
10. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
Li H; Jiang J
J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA 0000311 Aggravates the Aggressiveness of Oral Squamous Cell Carcinoma via miR-876-5p/EZH2 Axis.
Xu J; Lin Q; Zhao X
J Environ Pathol Toxicol Oncol; 2023; 42(3):43-52. PubMed ID: 37017678
[TBL] [Abstract][Full Text] [Related]
16. lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p.
Hou C; Wang X; Du B
Exp Ther Med; 2020 Aug; 20(2):978-984. PubMed ID: 32742341
[TBL] [Abstract][Full Text] [Related]
17. DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
Chen H; Cai K
In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):286-295. PubMed ID: 32377998
[TBL] [Abstract][Full Text] [Related]
18. lncRNA DSCAM-AS1 facilitates the progression of endometrial cancer via miR-136-5p.
Li L; Chen P; Huang B; Cai P
Oncol Lett; 2021 Dec; 22(6):825. PubMed ID: 34691252
[TBL] [Abstract][Full Text] [Related]
19. FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells.
Zhao W; Guo J; Li H; Cai L; Duan Y; Hou X; Diao Z; Shao X; Du H; Li C
BMC Cancer; 2021 Dec; 21(1):1310. PubMed ID: 34876040
[TBL] [Abstract][Full Text] [Related]
20. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis.
Yao Y; Liu Y; Jin F; Meng Z
Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
